Mapping cognitive dysfunction in relapsing multiple sclerosis with mild disability: A cross-sectional study from South India
- PMID: 39676817
- PMCID: PMC11639032
- DOI: 10.1177/20552173241304302
Mapping cognitive dysfunction in relapsing multiple sclerosis with mild disability: A cross-sectional study from South India
Abstract
Background: Cognitive dysfunction in multiple sclerosis (MS) occurs early. Locally adapted neuropsychological data from India in MS is scarce.
Objectives: We aimed to identify the pattern of cognitive impairment in relapsing MS (RMS) with mild disability using a regionally-adapted MS-specific cognitive battery.
Methodology: The study included 59 persons with MS (pwMS) with expanded disability status scale (EDSS)≤ 4 and 62 controls. The battery had 8 neuropsychological tests (Paced Auditory Serial Addition Test [PASAT], Symbol Digit Modalities Test [SDMT], Rey Auditory Verbal Learning Test [RAVLT], Brief Visuospatial Memory Test-Revised [BVMT-R], verbal fluency [VF], Judgement of Line Orientation Test [JOLOT], Wisconsin Card Sorting Test [WCST] and Trail Making Test-B [TMT-B]) with 11 measures. The scores were compared between the groups for pattern and associations of cognitive impairment.
Results: The pwMS cohort had 39 (66.1%) females; mean age of 32.56 (±8.17) years. Scores were significantly worse for pwMS in 10 of 11 tests (except JOLOT). Cohen's-d test showed the largest effect sizes for PASAT, SDMT, VF and TMT-B. Cognitive impairment (defined as ≥2 abnormal tests) were noted in 41 (69.5%) pwMS. Male sex was associated with cognitive impairment (p = 0.002).
Conclusions: In pwMS with mild disability, nearly two-thirds had cognitive abnormalities, predominantly involving processing speed, working memory, executive function, and VF.
Keywords: MACFIMS; Multiple sclerosis; RRMS; cognition; cognitive dysfunction.
© The Author(s), 2024.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures

Similar articles
-
Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.Arch Clin Neuropsychol. 2023 Jan 21;38(1):37-48. doi: 10.1093/arclin/acac059. Arch Clin Neuropsychol. 2023. PMID: 35901460
-
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.Neuroimage Clin. 2014 Dec 27;8:440-7. doi: 10.1016/j.nicl.2014.12.015. eCollection 2015. Neuroimage Clin. 2014. PMID: 26106524 Free PMC article.
-
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).Mult Scler Relat Disord. 2021 Feb;48:102692. doi: 10.1016/j.msard.2020.102692. Epub 2020 Dec 17. Mult Scler Relat Disord. 2021. PMID: 33352358
-
Comparing cognitive impairment using MACFIMS in patients with multiple sclerosis and healthy controls: a systematic review and meta-analysis.BMC Neurol. 2024 Nov 19;24(1):454. doi: 10.1186/s12883-024-03943-2. BMC Neurol. 2024. PMID: 39563246 Free PMC article.
-
Cognitive decline in Multiple Sclerosis patients.Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:75-81. Hell J Nucl Med. 2019. PMID: 30877725 Review.
References
-
- Johnen A, Landmeyer NC, Bürkner PC, et al. Distinct cognitive impairments in different disease courses of multiple sclerosis—a systematic review and meta-analysis. Neurosci Biobehav Rev 2017; 83: 568–578. - PubMed
-
- Rao SM, Leo GJ, Bernardin Let al. et al. Cognitive dysfunction in multiple sclerosis: I: frequency, patterns, and prediction. Neurology 1991; 41: 685–691. - PubMed
-
- Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549–558. - PubMed
LinkOut - more resources
Full Text Sources